<DOC>
	<DOCNO>NCT02305160</DOCNO>
	<brief_summary>The purpose study determine efficacy safety new pulmonary surfactant produce Butantan Institute among premature infant gestational age 34 week RDS , compare pulmonary surfactant commercially available Brazil .</brief_summary>
	<brief_title>A Multicenter , Randomized , Open Label Trial New Animal Extracted Surfactant Treat RDS Preterm Infants</brief_title>
	<detailed_description>Exogenous surfactant replacement therapy one major advance treatment premature infant respiratory distress syndrome ( RDS ) . It decrease mortality among premature infant RDS , determine change child mortality rate among developed country . High cost , however , major handicap wide use develop underdeveloped country . Based , Butantan Institute ( Sao Paulo , Brazil ) develop new porcine pulmonary surfactant preparation low production cost . Initial animal study show similar improvement lung mechanic histopathologic finding observe commercially available preparation . Comparison ( ) : The new surfactant develop produce Butantan Institute compare commercially available pulmonary surfactant Brazil , regard efficiency maintain good arterial oxygenation , low airway pressure treatment , similar mortality rate , similar rate complication like bronchopulmonary dysplasia pulmonary hemorrhage .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<mesh_term>Beractant</mesh_term>
	<mesh_term>Poractant alfa</mesh_term>
	<criteria>Gestational age 34 week RDS diagnosis base clinical RDS radiographic pattern Need mechanical ventilation Parental consent Age great 24 hour Major congenital malformation Unstable hemodynamic status Occurence seizure stay Neonatal Intensive Care Unit Maternal and/or fetal infection ( chorioamnionitis : maternal fever , foul vaginal discharge , fetal tachycardia , uterine tenderness , leukocytosis leukopenia ) congenital infection</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Respiratory distress syndrome</keyword>
	<keyword>Pulmonary surfactant</keyword>
	<keyword>Mortality</keyword>
	<keyword>Prematurity</keyword>
</DOC>